Press release
New Actos Bladder Cancer Resource Center Offers Answers to Concerned Patients
Los Angeles, CA, December 6, 2011 -- Nadrich & Cohen LLP, a prominent national law firm, has established a new website geared towards helping Actos users who developed bladder cancer after taking the drug. Visitors to the new site, www.SideEffectActos.com, can find the latest updates, news and information on the Actos bladder cancer litigation.The link between Actos and bladder cancer first came to light in September 2010, when the U.S. Food and Drug Administration published the results of a ten-year research study which indicated that patients who used the Type 2 diabetes drug were more susceptible to bladder cancer and other serious side effects. In June 2011, the FDA issued new warnings advising physicians and patients that using Actos for more than a year could substantially increase the risk of developing bladder cancer.
Since the new warnings were issued, approximately 3,500 Actos users have filed lawsuits in state and federal courts against Takeda Pharmaceuticals, the Japanese maker of the drug. A number of the lawsuits have been consolidated into a multidistrict litigation which will be heard in federal court. The FDA is conducting an ongoing safety review of Actos side effects but as of yet, there are no plans to recall the drug in the U.S.
Actos has already been pulled off the shelves in both France and Germany, citing the link between the drug and bladder cancer. Despite these actions, the European Medical Agency continues to support the use of Actos to treat Type 2 diabetes in adult patients when other treatment methods prove ineffective.
The law firm of Nadrich & Cohen is currently investigating Actos bladder cancer claims from patients in all 50 states. The firm created www.SideEffectActos.com in an effort to reach out to even more Actos users nationwide who’ve experienced serious side effects after taking the drug. In addition to finding a wealth of resources and information, visitors to the site can also complete a confidential online contact form to schedule a free initial case evaluation.
If you or someone you love has been diagnosed with bladder cancer after taking Actos, don’t hesitate to contact the experienced Actos injury team at Nadrich and Cohen today. Our Injury Hotline is available 24 hours a day, 7 days a week at 1-800-722-0765. We are eager to discuss your claim and we are committed to helping Actos bladder cancer patients get the compensation they’re entitled to.
###
Contact:
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd., Suite 1250
Los Angeles, CA 90025
800-718-4658
www.personalinjurylawcal.com
Nadrich & Cohen LLP is a national law firm specializing in assisting clients who've been injured by defective medical devices, harmful products and prescription drugs, car accidents, motorcycle accidents, bicycle accidents and dog bites.
Nadrich & Cohen LLP
12100 Wilshire Blvd
Suite 1250
Los Angeles, CA 90025
800-718-4658
www.personalinjurylawcal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Actos Bladder Cancer Resource Center Offers Answers to Concerned Patients here
News-ID: 203192 • Views: …
More Releases from Nadrich & Cohen, LLP
Johnson & Johnson Defends Withdrawal of PMA for Rejected Hips
Nadrich & Cohen, LLP reports that Johnson & Johnson is defending its withdrawal of a PMA for a rejected metal hip device that was reportedly sold overseas.
Los Angeles, CA, February 16, 2012 – The Johnson & Johnson Company is facing more criticism after a recent New York Times article revealed that the company continued to market a metal hip resurfacing system overseas, despite the fact that the FDA failed to…
Actos Bladder Cancer Lawsuits Continue to Mount as Attorneys Push for Consolidat …
With new Actos bladder cancer lawsuits being filed every day, the plaintiffs and their attorneys are urging for the consolidation of these cases. Some 3500 Actos lawsuits have been filed in state and federal courts across the country, including Illinois, New York, New Jersey, Ohio and California. The law firm of Nadrich & Cohen LLP is currently investigating claims from Actos users in all 50 states who claim they developed…
New Vaginal Mesh Safety Recommendations Issued
National law firm Nadrich & Cohen LLP is endorsing new recommendations issued by the American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society (AUGS) regarding the use of transvaginal mesh to treat pelvic organ prolapse in certain women.
In a joint statement, the two organizations called for physicians to limit their use of vaginal mesh only to high-risk women for whom other treatment methods would not be…
Actos Bladder Cancer Lawsuits Expected to Top 10,000
Los Angeles, CA, December 2, 2011 --- The number of lawsuits stemming from Actos bladder cancer claims may reach more than 10,000, according to a Bloomberg report. In response, national law firm Nadrich & Cohen, LLP has launched a new Actos bladder cancer resource website to assist patients in filing their claims.
Visitors to www.SideEffectActos.com can read up on the link between Actos and bladder cancer, get the latest updates…
More Releases for Actos
Initial Hearing Scheduled in Federal Actos Bladder Cancer Litigation
Nadrich & Cohen, LLP reports that the federal judge presiding over the consolidated Actos bladder cancer cases has scheduled the first hearing in the pending litigation.
Los Angeles, CA, February 14, 2012 – Judge Rebecca Doherty issued an order on Monday announcing that she would be appointing lead counsel for the consolidated Actos lawsuits following a March 22nd status conference set to take place in Lafayette, LA. Judge Doherty was assigned…
Federal Panel Votes to Consolidate Actos Bladder Cancer Lawsuits
Nadrich & Cohen LLP reports that a federal judicial panel has voted to consolidate pending Actos bladder cancer claims into a multidistrict litigation for pretrial proceedings.
Los Angeles, CA, January 5, 2012 – Plaintiffs in the Actos bladder cancer litigation have successfully moved to have the federal lawsuits consolidated into a multidistrict litigation for pretrial proceedings. The cases will be transferred to the Western District Court of Louisiana, with the…
More Actos Bladder Cancer Lawsuits Filed in Los Angeles
Nadrich & Cohen LLP reports that new lawsuits have been filed in Los Angeles against the maker of Actos by two patients who allege the drug caused bladder cancer.
Los Angeles, CA, December 30, 2011 – As Takeda Pharmaceuticals continues to battle litigation over its Type 2 diabetes drug Actos, three additional lawsuits were filed in a Los Angeles court. The newest claims join the thousands of other Actos lawsuits that…
Takeda Pharmaceuticals, Eli Lilly Face Actos Class Action Lawsuit in Canada
Los Angeles, CA, December 22, 2011 – A class action lawsuit was filed in an Ontario Superior Court against Japanese drug-maker Takeda Pharmaceuticals, alleging that the company knew its popular Type 2 diabetes drug Actos causes bladder cancer. The class action suit also names Eli Lilly as a defendant.
According to court records, the lead plaintiff in the action is a Toronto woman who began taking Actos in 2002. The…
Despite Bladder Cancer Lawsuits, Generic Actos May Hit Market Next Year
Takeda Pharmaceuticals, the manufacturer of Type 2 diabetes drug Actos, may face stiff competition from generic competitors when the drug’s patent expires in August 2012. The Japanese drug-maker also faces trouble on another front in the form of thousands of lawsuits filed by Actos users who allege the drug caused them to develop bladder cancer.
Takeda has previously settled lawsuits from a number of drug manufacturers which would allow the…
Nadrich & Cohen Now Reviewing Actos Bladder Cancer Claims
Los Angeles, CA, December 12, 2011 – Nadrich & Cohen LLP, a prominent national law firm, is now reviewing claims from Actos users in all 50 states who developed bladder cancer after taking the drug. In an effort to connect with even more Actos users across the country, the firm has established an online resource center at www.SideEffectActos.com.
Actos was approved by the U.S. Food and Drug Administration to treat adults…
